University of California San Francisco
Give to UCSF
UCSF researchers have found a way to knock down cancers caused by a tumor-driving protein called “myc,” paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.
The nation's premier pharmacy school capped its academic year by welcoming a new dean and celebrating a stellar class of graduates at its commencement ceremony on May 24.
The ability to form blood vessels is one of evolution’s crowning achievements. Now, scientists at the Gladstone Institutes have identified the molecular signals that direct the process of committing endothelial cells to become arteries or veins during embryonic development.
A new UCSF study highlights the potential importance of the vast majority of human DNA that lies outside of genes within the cell.
Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs lowered the risk of stroke by almost one-third, compared to aspirin alone, when given to patients who had minor or transient stroke symptoms to prevent subsequent attacks.
Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
Pharmacologist Lisa Bero, PhD, answers our questions about industry bias in clincial trials.
New research conducted at UCSF sheds lights on how fingers and toes are formed in the womb, a finding likely to fundamentally reshape biologists' understanding of how cells communicate to each other during development.
The Li Ka Shing Foundation has pledged $2 million to support UCSF’s efforts to advance precision medicine, an emerging field aimed at revolutionizing medical research and patient care.
<p>UCSF has named a highly accomplished pharmacist and clinical scientist, B. Joseph Guglielmo, PharmD, a 34-year member of the UCSF faculty, to lead the nation’s premier School of Pharmacy.</p>
Five UCSF scientists – bioengineers Tejal Desai and Shuvo Roy, MD/PhD candidate Mozziyar Etemadi, microbiologist Joe DeRisi, and physician/surgeon Michael Harrison – trace their path toward five inventions that are changing the face of medicine.
<p>Researchers at UCSF have identified the lynchpin that activates brown fat cells, which burn fat molecules instead of storing them, making them the focus of pharmaceutical research aimed at fighting obesity.</p>
<p>UCSF and its affiliates have been major players in the transformation of San Francisco as a leading center of innovation in health care and biosciences, according to a new report released Wednesday.</p>
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.